BXRXV

Baudax Bio (BXRXV)

Baudax Bio Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:BXRXV

1 2 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2020/06/10	05 : 33	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BXRXV	Baudax Bio Inc
2020/06/02	20 : 46	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BXRXV	Baudax Bio Inc
2020/05/14	05 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BXRXV	Baudax Bio Inc
2020/05/08	20 : 53	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BXRXV	Baudax Bio Inc
2020/05/08	20 : 32	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BXRXV	Baudax Bio Inc
2020/05/02	06 : 01	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:BXRXV	Baudax Bio Inc
2020/04/23	20 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BXRXV	Baudax Bio Inc
2020/04/04	06 : 11	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BXRXV	Baudax Bio Inc
2020/04/03	05 : 44	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BXRXV	Baudax Bio Inc
2020/04/02	23 : 00	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BXRXV	Baudax Bio Inc
2020/03/28	06 : 23	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:BXRXV	Baudax Bio Inc
2020/03/28	06 : 19	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:BXRXV	Baudax Bio Inc
2020/03/28	04 : 54	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BXRXV	Baudax Bio Inc
2020/03/28	04 : 52	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BXRXV	Baudax Bio Inc
2020/03/26	23 : 14	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BXRXV	Baudax Bio Inc
2020/03/25	06 : 05	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:BXRXV	Baudax Bio Inc
2020/03/24	22 : 33	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BXRXV	Baudax Bio Inc
2020/03/24	06 : 27	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:BXRXV	Baudax Bio Inc
2020/03/05	04 : 32	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BXRXV	Baudax Bio Inc
2020/02/21	23 : 29	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BXRXV	Baudax Bio Inc
2020/02/21	07 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BXRXV	Baudax Bio Inc
2020/02/14	20 : 24	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BXRXV	Baudax Bio Inc
2020/02/14	07 : 32	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:BXRXV	Baudax Bio Inc
2020/02/14	07 : 07	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:BXRXV	Baudax Bio Inc
2020/02/14	00 : 58	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BXRXV	Baudax Bio Inc
2020/02/11	21 : 59	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BXRXV	Baudax Bio Inc
2020/02/07	22 : 47	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BXRXV	Baudax Bio Inc
2020/01/22	22 : 52	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BXRXV	Baudax Bio Inc
2019/12/21	06 : 41	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BXRXV	Baudax Bio Inc
2019/12/17	20 : 01	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:BXRXV	Baudax Bio Inc